|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 278.45 USD | +0.32% |
|
+3.12% | +1.17% |
| Mar. 18 | The Cigna Group Presents at TD Cowen 46th Annual Health Care Conference, Mar-02-2026 01:50 PM | |
| Mar. 12 | Quest Diagnostics Incorporated Appoints Timothy Wentworth as Director | CI |
Company Valuation: Cigna
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 76,106 | 101,304 | 87,625 | 76,809 | 73,521 | 73,416 | - | - |
| Change | - | 33.11% | -13.5% | -12.34% | -4.28% | -0.14% | - | - |
| Enterprise Value (EV) 1 | 104,695 | 126,473 | 110,733 | 101,231 | 97,308 | 93,708 | 89,362 | 84,830 |
| Change | - | 20.8% | -12.45% | -8.58% | -3.88% | -3.7% | -4.64% | -5.07% |
| P/E ratio | 14.6x | 15.6x | 17.2x | 22.8x | 12.4x | 11.5x | 9.99x | 9.09x |
| PBR | 1.57x | 2.21x | 1.89x | 1.84x | 1.74x | 1.64x | 1.52x | 1.25x |
| PEG | - | 0.4x | -0.9x | -0.8x | 0.1x | 1.23x | 0.7x | 0.91x |
| Capitalization / Revenue | 0.44x | 0.56x | 0.45x | 0.31x | 0.27x | 0.26x | 0.25x | 0.23x |
| EV / Revenue | 0.6x | 0.7x | 0.57x | 0.41x | 0.35x | 0.33x | 0.3x | 0.27x |
| EV / EBITDA | 9.42x | 11x | 9.24x | 8.38x | 7.88x | 7.21x | 6.32x | 5.73x |
| EV / EBIT | 13.2x | 15x | 13x | 10.7x | 10.6x | 9.7x | 8.66x | 7.73x |
| EV / FCF | 17.3x | 17.2x | 10.8x | 11.3x | - | 10.3x | 8.78x | 7.94x |
| FCF Yield | 5.77% | 5.82% | 9.25% | 8.85% | - | 9.75% | 11.4% | 12.6% |
| Dividend per Share 2 | 4 | 4.48 | 4.92 | 5.6 | - | 6.215 | 6.488 | 6.775 |
| Rate of return | 1.74% | 1.35% | 1.64% | 2.03% | - | 2.23% | 2.33% | 2.43% |
| EPS 2 | 15.73 | 21.3 | 17.39 | 12.12 | 22.18 | 24.25 | 27.87 | 30.64 |
| Distribution rate | 25.4% | 21% | 28.3% | 46.2% | - | 25.6% | 23.3% | 22.1% |
| Net sales 1 | 174,078 | 180,642 | 195,322 | 247,099 | 274,900 | 282,786 | 299,260 | 315,448 |
| EBITDA 1 | 11,118 | 11,522 | 11,980 | 12,083 | 12,351 | 13,004 | 14,136 | 14,792 |
| EBIT 1 | 7,935 | 8,414 | 8,536 | 9,417 | 9,200 | 9,661 | 10,314 | 10,980 |
| Net income 1 | 5,365 | 6,668 | 5,164 | 3,434 | 5,957 | 6,465 | 7,481 | 7,784 |
| Net Debt 1 | 28,589 | 25,169 | 23,108 | 24,422 | 23,787 | 20,292 | 15,945 | 11,413 |
| Reference price 2 | 229.63 | 331.34 | 299.45 | 276.14 | 275.23 | 278.45 | 278.45 | 278.45 |
| Nbr of stocks (in thousands) | 331,428 | 305,739 | 292,620 | 278,153 | 267,126 | 263,661 | - | - |
| Announcement Date | 2/3/22 | 2/3/23 | 2/2/24 | 1/30/25 | 2/5/26 | - | - | - |
1USD in Million2USD
Estimates
P/E ratio, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 11.48x | 0.33x | 7.21x | 2.23% | 73.42B | ||
| 18.27x | 0.73x | 11.69x | 2.87% | 279B | ||
| 13.23x | 0.47x | 9.15x | 2.23% | 69.61B | ||
| 22.31x | 0.21x | 12.56x | 1.98% | 23.69B | ||
| 19.44x | 0.09x | 9.16x | -.--% | 18.47B | ||
| 44.46x | 0.15x | 10.15x | -.--% | 7.56B | ||
| 163.07x | 0.77x | 26.56x | -.--% | 4.37B | ||
| 14.14x | 0.82x | 4.84x | -.--% | 1.29B | ||
| -266.76x | 0.3x | 15.22x | -.--% | 1B | ||
| 47.8x | 2.68x | 14.15x | 0.58% | 286M | ||
| Average | 8.74x | 0.66x | 12.07x | 0.99% | 47.83B | |
| Weighted average by Cap. | 17.89x | 0.57x | 10.68x | 2.44% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Equities
- CI Stock
- Valuation Cigna
Select your edition
All financial news and data tailored to specific country editions
















